Atria Wealth Solutions Inc. Cuts Position in Exelon Corporation $EXC

Atria Wealth Solutions Inc. decreased its position in Exelon Corporation (NASDAQ:EXCFree Report) by 42.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,863 shares of the company’s stock after selling 6,627 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in Exelon were worth $385,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Providence Wealth Advisors LLC raised its position in Exelon by 0.6% in the first quarter. Providence Wealth Advisors LLC now owns 39,342 shares of the company’s stock valued at $1,802,000 after purchasing an additional 217 shares during the period. Hazlett Burt & Watson Inc. raised its position in Exelon by 46.4% in the first quarter. Hazlett Burt & Watson Inc. now owns 694 shares of the company’s stock valued at $32,000 after purchasing an additional 220 shares during the period. CWM LLC raised its position in Exelon by 0.7% in the first quarter. CWM LLC now owns 33,775 shares of the company’s stock valued at $1,556,000 after purchasing an additional 226 shares during the period. Catalyst Financial Partners LLC raised its position in Exelon by 2.4% in the first quarter. Catalyst Financial Partners LLC now owns 9,761 shares of the company’s stock valued at $450,000 after purchasing an additional 230 shares during the period. Finally, Focus Partners Wealth raised its position in Exelon by 0.6% in the first quarter. Focus Partners Wealth now owns 39,831 shares of the company’s stock valued at $1,836,000 after purchasing an additional 234 shares during the period. Hedge funds and other institutional investors own 80.92% of the company’s stock.

Exelon Stock Performance

Shares of EXC stock opened at $48.24 on Tuesday. The company has a current ratio of 0.95, a quick ratio of 0.85 and a debt-to-equity ratio of 1.66. The firm has a fifty day moving average price of $44.70 and a 200 day moving average price of $44.40. The company has a market cap of $48.72 billion, a P/E ratio of 18.34, a PEG ratio of 2.96 and a beta of 0.40. Exelon Corporation has a 12 month low of $35.94 and a 12 month high of $48.29.

Exelon (NASDAQ:EXCGet Free Report) last issued its earnings results on Thursday, July 31st. The company reported $0.39 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.02. The firm had revenue of $5.43 billion during the quarter, compared to the consensus estimate of $5.47 billion. Exelon had a net margin of 11.16% and a return on equity of 9.85%. The company’s revenue was up 1.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.47 earnings per share. Exelon has set its FY 2025 guidance at 2.640-2.740 EPS. Sell-side analysts predict that Exelon Corporation will post 2.64 earnings per share for the current fiscal year.

Exelon Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, September 15th. Investors of record on Monday, August 11th were paid a dividend of $0.40 per share. The ex-dividend date was Monday, August 11th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.3%. Exelon’s payout ratio is presently 60.84%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on EXC. UBS Group upped their price objective on Exelon from $48.00 to $50.00 and gave the stock a “neutral” rating in a research report on Friday, October 10th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Exelon in a research report on Wednesday, October 8th. TD Cowen began coverage on Exelon in a research report on Thursday, October 16th. They set a “hold” rating and a $49.00 price objective on the stock. KeyCorp upped their price objective on Exelon from $37.00 to $42.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 15th. Finally, Morgan Stanley cut their price objective on Exelon from $50.00 to $49.00 and set an “equal weight” rating on the stock in a research report on Thursday, September 25th. Six analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Exelon presently has a consensus rating of “Hold” and an average price target of $50.00.

Check Out Our Latest Report on EXC

About Exelon

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Recommended Stories

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Corporation (NASDAQ:EXCFree Report).

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.